About Daiichi Sankyo
WE’RE DAIICHI SANKYO’S
DIGITAL INNOVATION HUB.
You can read it as Digital SPACE, representing our engagement at the forefront of digital innovation to leverage digital technologies for improved patient outcomes, or DS-PACE referring to Daiichi Sankyo Europe’s pace moving forward to become an innovative healthcare company and contribute to the sustainable development of society.
Digital
So, why DSPACE? Because in a world where medical knowledge doubles every 71 days (1) our business model is adapting to these new realities. Personalised medicine, sensor technology and live tracking of medical data offer new opportunities to detect and diagnose medical conditions earlier, support patients more effectively during their treatment journey and develop new therapeutic approaches.
Our goal is to go beyond the health benefits of our medicines, delivering additional value by comprehensively understanding the needs of both patients and healthcare professionals (HCPs) throughout the entire treatment journey. We aim to ensure that our support addresses not only the efficacy of our treatments, but also the broader needs and experiences of those involved in the care process.
Strategy
Envision innovation as a limitless cosmos: we’re not superheroes but passionate astronauts navigating our area of expertise in the galaxy, providing value beyond the pill for patients, health care providers and payors.
DSPACE strategically complements Daiichi Sankyo Europe ́s portfolio in cardiovascular and oncology – focussing on cardiovascular first. These are the areas in which we can truly make a significant impact, leveraging our expertise, resources, and pursuit of excellence:
- Using new digital technologies to identify people in risk of medical conditions earlier
- Providing holistic support to patients through the provision of add-on services that complement our medicines
- Supporting HCPs in making more informed decisions with patients
Patient
At Daiichi Sankyo, ‘we care for every heartbeat’. Our mission is to protect individuals from cardiovascular disease (CVD) and support those affected by them, ensuring they enjoy every precious moment in life. ‘Together for patients, together for those who stand beside them’, we strive to make a difference cultivating a patient-centric mindset, aiming at delivering improved patient outcomes. We involve patients in the development of the digital solutions we’re working on in order to ensure they meet real-world needs and enhance the quality of care provided.
Approach
DSPACE is your partner of choice when it comes to digital health. Why? Because we act as a bridge between healthcare providers, payors and innovative healthcare technology companies. We are partnering with digital health start-ups that shake up the healthcare ecosystem within our areas of expertise and strategic scope, solving old problems with new solutions.
What do we bring to the table? Daiichi Sankyo brings more than 120 years of expertise in medicine development, clinical practice, market access and commercialisation of health solutions.
Alone we go faster, together we go farther. Let’s join forces and transform the way we provide healthcare for the sustainable development of society.
Culture
Navigating change isn’t always straightforward, but our secret sauce is forming a coalition of passionate and like-minded innovators. Together, we will master the art of failing fast, embrace failures as learning opportunities, and tackle innovation with a test-and-learn mindset.
Our approach involves falling in love with the problem, thoroughly understanding the need instead of chasing the latest technology trends. This is why we embark on the innovation journey by identifying unmet needs in each of the 13 European local markets. When we discover a solution that brings significant value, we leverage our collective expertise and resources to scale it up from one country to the rest of Europe, ensuring widespread impact.
Evolution
Daiichi Sankyo’s vision is to become an innovative global healthcare company, contributing to the sustainable development of society by 2030. DSPACE serves as a crucial asset in this transformative journey. Currently, we work on various opportunities to create value for our customers and their patients that complement our offering beyond our medicines in Europe. Ultimately, we aim at supporting the healthcare systems by addressing their needs with more sustainable solutions, delivering better patient outcomes in the future. It’s not on one player who can change the healthcare ecosystem to master the challenges of the future (among them aging population; scarcity of labour). The call is for all of us to be part of that change now, embracing a holistic perspective for a brighter and broader vision of healthcare!
(1) Densen P. Challenges and Opportunities Facing Medical Education. Transactions of the American Clinical and Climatological Association. 2011;122:48-58.
Daiichi Sankyo is an innovative global healthcare company contributing to the sustainable development of society that discovers, develops, and delivers new standards of care to enrich the quality of life around the world. With more than 120 years of experience, Daiichi Sankyo leverages its world-class science and technology to create new modalities and innovative medicines for people with cancer, cardiovascular, and other diseases with high unmet medical need.